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Current European surveillance regulations for scrapie, a naturally occurring transmissible
spongiform encephalopathy (TSE) or prion disease in sheep and goats, require testing
of fallen stock or healthy slaughter animals, and outline measures in the case of
confirmation of disease. An outbreak of classical scrapie in a herd with 2500 goats
led to the culling of the whole herd, providing the opportunity to examine a subset of
goats, take samples, and examine them for the presence of disease-associated prion
protein (PrPSc) to provide further information on scrapie test sensitivity, pathology, and
association with prion protein genotype. Goats were examined clinically prior to cull,
and the brains examined post mortem by Bio-Rad ELISA, a rapid screening test used
for active surveillance in sheep and goats, and two confirmatory tests, Western blot
and immunohistochemistry. Furthermore, up to 10 lymphoid tissues were examined by
immunohistochemistry. Of 151 goats examined, three (2.0%) tested positive for scrapie
by ELISA on brain, confirmed by confirmatory tests, and a further five (3.3%) were
negative by ELISA but positive by at least one of the confirmatory tests. Only two of
these, both positive by ELISA, displayed evident signs of scrapie. In addition, 10 (6.6%)
goats, which also included two clinical suspects, were negative on brain examination
but had detectable PrPSc in lymphoid tissue. PrPSc was detected most frequently in
the medial retropharyngeal lymph node (LN; 94.4% of all 18 cases) and palatine tonsil
(88.9%). Abnormal behavior and circling or loss of balance when blindfolded were the
best clinical discriminators for scrapie status. None of the goats that carried a single
allele in the prion protein gene associated with increased resistance to scrapie (Q211,
K222, S146) were scrapie-positive, and the percentage of goats with these alleles was
greater than expected from previous surveys. Significantly more goats that were scrapie-
positive were isoleucine homozygous at codon 142 (II142). The results indicate that the
sensitivity of the applied screening test is poor in goats compared to the confirmatory
tests as gold standard, particularly for asymptomatic animals. Sensitivity of surveillance
could be improved by testing retropharyngeal LN or palatine tonsil in addition to brain.
Keywords: transmissible spongiform encephalopathy, prion, classical scrapie, goat, clinical diagnosis,
immunohistochemistry, ELISA
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INTRODUCTION
Scrapie is a naturally occurring transmissible spongiform
encephalopathy (TSE) in sheep and goats, which causes
neurological signs and ultimately leads to death. The disease
is caused by misfolding of the prion protein, which makes
the physiological, cellular form (PrPC) resistant to enzymatic
digestion with proteinases (Prusiner, 1995). In the absence of
a reliable and quick test in a live animal, disease suspicion
is currently based on clinical examination, which needs to be
confirmed in the dead animal by examination of the brain. The
majority of diagnostic tests are based on the detection of the
misfolded scrapie prion protein (PrPSc) (Gavier-Widén et al.,
2005). Two scrapie types exist, atypical and classical scrapie,
which are epidemiologically distinct and produce different
disease phenotypes. Contrary to classical scrapie, atypical scrapie
usually affects single and older animals, the agent is less resistant
to proteolytic digestion with proteinase K, PrPSc is not detectable
in lymphoid tissue by immunohistochemical examination (IHC)
and relatively absent in the brainstem. Different biochemical
profiles are also identified on Western blot examination of brain
(Benestad et al., 2008). Scrapie is a World Organization for
Animal Health (OIE) listed disease, although management of
the animal health risks associated with the scrapie agent in the
OIE’s Terrestrial Animal Health Code (OIE, 2018) only applies
to classical scrapie, due to the known contagious nature of
this disease type. In Europe, rules for the prevention, control,
and eradication of classical scrapie are laid down in European
Parliament and Council Regulation (EC) No 999/2001. In
addition to the examination of reported clinical suspects, this
requires active surveillance for TSEs by testing brain tissue from
healthy slaughter animals or animals that died or were killed
on farm (fallen stock), where surveillance stream and minimum
number of tested animals is dependent on the animal population
in each member state. In the United Kingdom, a minimum
of 500 fallen goats over 18 months of age need to be tested.
Regulation (EC) No 999/2001 currently lists four rapid TSE tests
that can be used for brain examination. In case of a positive
result, the sample requires examination by confirmatory tests,
such as Western immunoblot (WB) or immunohistochemistry
(European Parliament Council of the European Union, 2001).
If classical scrapie is confirmed in a holding, there are different
options for disease eradication: complete herd cull, cull of
susceptible animals only (in sheep), or no cull provided that
animals, at the end of their productive lives, are slaughtered
in the country of origin and those over 18 months of age are
tested for scrapie.
Susceptibility to scrapie is influenced by polymorphisms in
the prion protein gene (PRNP), principally at codons 136, 154,
and 171, and selection for resistant genotypes has led to a great
reduction in classical scrapie cases in sheep within the European
Union (EFSA, 2014). Recent research has shown that there are
also polymorphisms associated with lower risk toward classical
scrapie in the caprine PRNP: at codon 142 [methionine (M)
instead of isoleucine (I)], at codon 146 [serine (S) or aspartate (D)
instead of asparagine (N)], at codon 154 [histidine (H) instead
of arginine (R)], at codon 211 [glutamine (Q) instead of R]
and 222 [lysine (K) instead of Q] (Barillet et al., 2009). Based
on current scientific evidence, the K222, D146, and S146 alleles
have been shown to confer genetic resistance to classical scrapie
strains known to occur in the EU goat population [EFSA Panel
on Biological Hazards (BIOHAZ) et al., 2017] although genotype-
based scrapie eradication is currently not an approved option for
goats in the EU regulation.
There are only a few reports on classical scrapie outbreaks
in large goat herds, where goats were subject to clinical
examinations (González et al., 2009) and postmortem
examinations, which included assessment of PrPSc distribution
in lymphoid tissue (González et al., 2009, 2010; Corbière et al.,
2013a,b; Ortiz-Pelaez et al., 2015). These demonstrated that
up to 50% of goats might be infected, even though the brain
examination was negative. It has also been shown that brain
examination by immunohistochemistry may be superior to
testing by rapid tests in goats with classical scrapie (González
et al., 2009; Ortiz-Pelaez et al., 2015).
Following an outbreak of classical scrapie in a goat farm in
Great Britain in 2012, the decision was made to cull the whole
herd (more than 2000 goats) which required the testing of a
minimum subset of 150 goats over 18 months of age, according to
Regulation (EC) No 999/2001. The study reported here describes
the outcome of further investigations of this subset.
MATERIALS AND METHODS
Herd and Case History
The affected farm was a dairy goat herd with 2500 goats. It was
established in 2007 by purchasing 600 female goats from one
farm and five male goats from another farm. More goats were
subsequently purchased from eight different farms to increase
herd size, and female and male goats from other farms were
added to the herd annually. According to the owner, all goats
were purchased from herds that had been monitored for scrapie.
The main breeds were Saanen, Toggenburg, and Alpine. Pregnant
does gave birth indoors. Adult does were routinely vaccinated
against clostridial disease (Heptavac Plus, MSD Animal Health,
Milton Keynes, United Kingdom) and enzootic abortion (Cevac
Chlamydia, Ceva Animal Health, Amersham, United Kingdom).
The farm had a history of sheep occupancy, although there was
no known history of scrapie in these sheep. Classical scrapie was
first detected in a fallen stock goat in March 2012, which resulted
in TSE monitoring of all slaughtered or dead animals over
18 months of age. The scrapie prevalence based on postmortem
test examination of the brain from clinical suspects and fallen
stock over a 4-year period (2012–2015) was 2.8% in 2012, 3.6%
in 2013, 2.7% in 2014, and 2.4% in 2015 (mean 2.9%; 95%
confidence interval: 2.06, 3.69).
In 2014, the farmer took part in the survey of the national goat
population to determine the proportion of goats with a scrapie
resistant K222 allele of the PRNP (Goldmann et al., 2016) but none
of the 16 billies and 14 does used for breeding carried this allele.
The farmer reported the first clinical suspect in March
2015, which was confirmed positive. Eleven further cases were
reported as clinical suspects up to January 2016, of which
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five tested positive for scrapie based on examination of the
brain. One goat that tested negative in brain had lymphoid
tissue tested retrospectively, and presented with PrPSc by
immunohistochemistry in medial retropharyngeal lymph node
(LN), mesenteric LN, spleen, distal ileum, and recto-anal mucosa-
associated lymphoid tissue (RAMALT).
In February 2016, after it was decided to cull the herd, 151
female goats were transported to APHA Weybridge for clinical
examination and more extensive investigation by postmortem
tests. Goats were to some degree selected randomly from 920
lactating and 25 non-lactating goats (the farmer was asked to
pick the goats randomly), but the group included any goats with
possible clinical signs of scrapie, and all the goats selected were at
least 24 months old (minimum age of previous confirmed scrapie
cases) and born on the farm, even though at least five of 56
previously confirmed scrapie cases were born on a different farm.
Herd cull was carried out under Regulation (EC) No.
999/2001 and the relevant national Transmissible Spongiform
Encephalopathies (England) Regulations to eradicate scrapie and
no licensed procedures were undertaken in animals that would
have required ethical approval. However, the same standard for
animal care and housing that is generally applied to animals
used for scientific procedures under the Animal (Scientific
Procedures) Act 1986 was applied.
Clinical Assessment
Although goats were assessed at least twice daily by animal
technicians during normal husbandry procedures, specific
clinical examinations for signs of scrapie were only done once
prior to cull and provided the clinical data for analysis. Goats
were group-housed and examined in their pen for between 1
and 51 days after arrival (median 22 days) and up to 50 days
(median 5 days) prior to cull. Cull had to be scheduled over
63 days due to availability of staff and postmortem room, and
goats with clinical disease (not necessarily scrapie) or those
that were heavily lactating were culled first. All goats were
female with a median age of 36 months (range: 24–72 months)
based on the farmer’s records. There were 102 (68%) lactating
goats, which were milked daily and dried off depending on cull
date and milk volume generated. A short examination protocol
was used to assess body condition, posture and movement,
behavior, pruritus, and vision (Konold and Phelan, 2014), which
differed from the one used previously (Konold et al., 2010) in
that it also included blindfolding to assess vestibular system
function. Animal handling was limited to the assessment of the
menace response, scratch test, body condition, and response to
blindfolding, and the animal was visually inspected in the pen
to assess behavior, locomotion, tremor, hair or skin changes,
and response to a hand clap. Based on the observed signs,
an animal was regarded as “showing no evidence of scrapie”,
“inconclusive with regards to scrapie”, or “clinical suspect” prior
to cull. To be inconclusive, the animal had to display one of
the signs: repeatable response to scratching (positive scratch
test), tremor, abnormal behavior, circling, collapsing episodes,
ataxia/dysmetria, or a uni- or bilateral absent menace response,
whereas a suspect had to clearly and consistently display more
than one of these signs (Konold and Phelan, 2014).
The clinical diagnosis was compared with the postmortem
diagnosis (see below) to establish diagnostic sensitivity
(percentage of animals with scrapie that have disease suspicion
based on clinical signs) and specificity (percentage of animals
without scrapie that do not have suspicious signs of scrapie).
Postmortem Examination
Goats were euthanized by intravenous barbiturate overdose
(10 ml Somulose, Dechra, Shrewsbury, United Kingdom) and
exsanguination. The following tissues were collected: brain,
lateral and medial retropharyngeal LN, submandibular LN,
palatine tonsil, pre-scapular LN, pre-femoral LN, mesenteric
LN, spleen, distal ileum, and rectal tissue containing RAMALT.
The brain was cut sagittally, the right side fixed with 10%
formol saline and the left side frozen. Lymphoid tissue was
fixed in 10% buffered formalin. The right side of the obex
was submitted to an approved TSE testing site (Eurofins
Forensic Services, Risley, United Kingdom) for rapid testing
(TeSeE ELISA, Bio-Rad Laboratories, Watford, United Kingdom)
to detect the proteinase-resistant prion protein PrPres. Tissue
processing for IHC with monoclonal antibody R145 (APHA
Weybridge, New Haw, United Kingdom) was as described
previously for brain (Dustan et al., 2008). R145 is a rat
monoclonal antibody, which recognizes the epitope 231-
RESQA-235 of the bovine prion protein and was applied to
sections for 60 min at a dilution of 1:150. Brain sections
for IHC included the medulla oblongata at the level of
the obex (all cases), rostral medulla at the level of the
cerebellar peduncles, cerebellum, thalamus, and cerebrum at
the level of frontal cortex (all cases with no detectable
PrPSc in the obex). All obex samples that were tested by
rapid test were also tested by discriminatory WB using the
methodology described previously (Simmons et al., 2016),
with the exception of two goats where caudal medulla was
tested instead due to lack of remaining obex. The WB is
based on the Bio-Rad TeSeE Universal Western Blot using
the manufacturer’s instructions. Two replicate gels were run
with 18.75 mg tissue equivalent per well. Primary antibodies
were Sha31 (Bio-Rad Laboratories, directed against the 148-
YEDRYYRE-155 epitope), which was prepared according to the
manufacturer’s kit instructions, and the N-terminal antibody
P4 (R-Biopharm Rhône Ltd., Glasgow, United Kingdom,
directed against the 93-WGQGGSH-99 epitope), which was
used in a dilution 1:5000 of a stock solution of 1 mg/ml.
Incubation times for the Sha31 and P4 antibodies were
30 and 60 min, respectively. Additional investigations were
requested for clinical suspects with neurological signs in
which scrapie was not confirmed, which included staining
of brain sections with hematoxylin-eosin (Dustan et al.,
2008) and gram-staining in cases with inflammatory changes
(Stevens and Bancroft, 1982).
A 1 g piece of frontal cortex was submitted fresh from each
goat to determine the full open reading frame of the caprine
PRNP using the same equipment, reagents, primers, and protocol
as published previously (Konold et al., 2010). For the purpose of
this study, polymorphisms are reported for codons 142, 146, 154,
211, 222, and 240.
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Statistical Calculations
All calculations were carried out using Statistica (version 13.5,
TIBCO, Dublin, Ireland).
To find retrospectively the best clinical markers for
disease suspicion using confirmatory tests on brain as
gold standard (see below), classification and regression
tree analysis was used (Breiman et al., 1984). Categorical
dependent variables were the TSE status based on brain
examination (positive, negative), and factor codes were
the clinical variables tremor (yes, no), mental status
(normal, abnormal), behavior resting/approached/handled
(normal, abnormal), menace response (normal, impaired,
exaggerated), scratch test (negative, positive, inconclusive),
body condition (good, poor), ataxia (no, yes), circling or
loss of balance when blindfolded (yes, no), skin lesions
(yes, no), skin lesion frequency (none, one, more than
one), hair loss (yes, no), hair loss frequency (none,
one, more than one), short hair (yes, no), and short
hair frequency (none, one, more than one). Equivocal
signs (e.g., inconsistent menace response, temporary
circling when blindfolded or possibly ataxia) were still
classified as abnormal.
To compare the age of goats between groups (scrapie-
negative, scrapie-positive in lymphoid tissue only, scrapie-
positive in brain), age distribution was assessed for normality
in box and whisker plots and an appropriate test used
(ANOVA or the non-parametric Kruskall–Wallis if data were not
normally distributed).
To assess whether false negative results in the screening ELISA
test were associated with higher optical density (OD) values than
true negative results, OD values for each sample were divided
by the cut-off specified for each test run to calculate an OD
cut-off ratio (multiplied by 100). The ratios were grouped by
PRNP genotype at codon 142 based on recent findings that PRNP
polymorphisms may affect test sensitivity in goats (Simmons
et al., 2020), and the data compared by non-parametric Mann–
Whitney U-test. This test was also used to compare the ages
of goats with a false negative and true negative ELISA result,
grouped by genotype at codon 142.
To determine whether scrapie status was associated with
particular genotypes, the proportion of scrapie-positive and
negative animals carrying each polymorphism was compared by
Fisher’s exact test; P < 0.05 was indicative of an association of
genotype with scrapie status.
RESULTS
All data can be found as a supplementary file (Supplementary
Table S1). Animal data, test results, and clinical status of these
scrapie cases are displayed in Table 1.
Following the clinical examination, 12 goats (8%) were
classified as clinical suspects, 32 (21%) were inconclusive with
regard to scrapie, and 107 (71%) showed no evidence of scrapie.
The pathological examination identified 18 goats (11.9%) with
PrPSc indicative of infection with the scrapie agent.
Three goats (2.0%) tested positive on brain examination by the
rapid test, confirmed by IHC and WB. Five goats (3.3%) were
rapid test-negative but positive on the confirmatory tests.
In addition, there were 10 goats (6.6%), which had PrPSc
in lymphoid tissue, but brain examination was negative. The
WB profile (see Figure 1 for examples) or presence of PrPSc in
TABLE 1 | Scrapie case data.
Goat ID Breed Age [m] PRNP Genotype ELISA (obex) IHC obex WB (obex or caudal medulla) IHC (lymphoid tissue) Clinical status
2113 TO 60 II142 PP240 P P P P SuspectI
2135 SA 36 II142 PP240 P P P P Suspect
2073 TO 60 II142 SP240 P P P** P Inconclusive
2146 SA 24 II142 PP240 N P* N** P Inconclusive
2165 AL 24 II142 SP240 N P* Inconclusive P No evidence
2176 TO 24 II142 SS240 N P P P No evidence
2078 AL 72 II142 PP240 N P P P No evidence
2117 SA 24 IM142 PP240 N N P P No evidence
2191 TO 60 II142 SP240 N N N P Suspect
2169 SA 60 IM142 PP240 N N N P SuspectII
2179 AL 24 II142 SP240 N N N P Inconclusive
2112 SA 60 II142 PP240 N N N P Inconclusive
2166 TO 24 IM142 SP240 N N N P No evidence
2201 TO 60 IM142 PP240 N N N P No evidence
2126 SA 60 II142 PP240 N N N P No evidence
2182 SA 24 II142 PP240 N N N P No evidence
2143 TO 60 II142 SP240 N N N P No evidence
2155 TO 24 II142 SP240 N N N P No evidence
AL = Alpine, SA = Saanen, TO = Toggenburg. All goats were GG127, RR211, and QQ222. *Minimal immunolabeling; **caudal medulla was tested; P = positive, N = negative;
one WB result was classified as inconclusive because of an extremely weak band at approximately 27 kDa (the PrPres region), Ivideo clip “classical scrapie in goats” of
this animal available to view at https://www.youtube.com/watch?v=Kkhak9yJ3H0 (Konold and Vallino Costassa, 2018); IIsee Supplementary Video File S1.
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FIGURE 1 | Western blot profile of digested brain samples from selected
goats using two monoclonal antibodies. (A) Sha31 antibody. (B) P4 antibody.
Lanes 1 and 10: molecular mass marker; lane 2: goat 2135 (clinical suspect,
positive on brain by IHC and ELISA); lane 3: goat 2113, clinical suspect,
positive on brain by IHC and ELISA); lane 4: goat 2078 (no clinical signs of
scrapie, positive on brain by IHC, negative by ELISA); lane 5: goat 2117 (no
clinical signs of scrapie, negative on brain by IHC and ELISA, positive on
lymphoid tissue by IHC; scrapie profile difficult to discern with the picture
contrast used); lane 6: goat 2102 (clinical suspect, negative on brain by ELISA
and on all tissues by IHC); lane 7: caprine classical scrapie control (RSCRAP
17/00006, II142QQ222); lane 8: bovine classical BSE control (RBSE 98/00291);
lane 9: ovine classical scrapie control (PG1903/97).
lymphoid tissue (see Figure 2 for examples) was suggestive of
classical scrapie in all cases.
Two goats (2153—scrapie-negative and 2179—scrapie-
positive in lymphoid tissue only) had encephalitic lesions in the
brain suggestive of listeriosis, and gram-staining identified gram-
positive rods in 2153. Goat 2153, which presented with multifocal
severe suppurative encephalitis, developed neurological signs
7 days after being examined for scrapie, which included inability
to stand unaided, head tilt and turn to the right and vertical
nystagmus suggestive of a vestibular disease, and was euthanized.
It had been clinical unremarkable with no evidence of scrapie
at the time of the examination for scrapie. Goat 2179, which
presented with moderate focal necrotizing, granulomatous
encephalitis, was euthanized 5 days after the examination and
considered inconclusive with regard to scrapie because of the
display of a head tremor and temporary anti-clockwise circling
when blindfolded. It presented with PrPSc in lymphoid tissue.
By contrast, a goat (2102) that displayed a head tremor and
ataxia with hind limb weakness, which was considered a scrapie
suspect, had neither scrapie confirmed nor any other noticeable
lesions in the brain.
All cases that were positive by examination of the brain also
had PrPSc in lymphoid tissue. A total of 144 goats (95%) had
the whole range of lymphoid tissue suitable for examination.
The tissue that presented with PrPSc most frequently was the
medial retropharyngeal LN, the least frequent the spleen (see
Table 2). PrPSc was detected in all 10 lymphoid tissues in the three
cases with a positive brain ELISA result and in one case with a
FIGURE 2 | Immunohistochemical examination of brain and lymphoid tissue
from selected goats. Obex (A) and medial retropharyngeal LN (B) from clinical
suspect goat 2135, positive on brain by ELISA and WB; obex (C) from goat
2146 with inconclusive signs with regard to scrapie, negative on brain by
ELISA and WB and pre-scapular LN (D) from clinical suspect goat 2169,
negative by all tests on brain, PrPSc detected in pre-scapular LN only. Note the
comparatively sparser PrPSc accumulation in the obex in C (immunolabeling
visible in only one neuron) compared to A. Immmunolabeling is restricted to
tingible body macrophages in the pre-scapular LN in D whereas
macrophages and follicular dendritic cells are both immunolabeled in B.
TABLE 2 | PrPSc accumulation in ten peripheral issues in the 18
scrapie-positive goats.
Tissue (N examined) PrPSc positive (% of
scrapie-affected goats)
Medial retropharyngeal LN (151) 17 (94.4%)
Palatine tonsil (151) 16 (88.9%)
Submandibular LN (149) 13 (72.2%)
Mesenteric LN (151) 13 (72.2%)
Pre-scapular LN (151) 13 (72.2%)
Distal ileum (151) 12 (66.7%)
Pre-femoral LN (151) 11 (61.1%)
Lateral retropharyngeal LN (148) 9 (50.0%)
RAMALT (149) 9 (50.0%)
Spleen (151) 7 (38.9%)
negative ELISA but positive confirmatory brain test result. It was
more variable in the other scrapie cases and one goat (2169) had
detectable PrPSc only in the pre-scapular LN.
The mean age of animals positive for scrapie in brain (N = 8,
mean 41 months, range 24–72 months), positive in lymphoid
tissue only (N = 10, mean 46 months, range 24–60 months),
and scrapie-negative animals (N = 133, mean 39 months, range
24–72 months) was not significantly different (P = 0.67, Kruskall–
Wallis test on not normally distributed ages).
Sensitivity and specificity of the clinical examination were
25 and 93%, respectively, using brain examination as the gold
standard and only clinical suspects as scrapie-affected. Inclusion
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of clinically inconclusive cases as also scrapie-affected would
double sensitivity but reduce specificity to 72% with the brain
examination as gold standard.
The results from the classification and regression tree analysis
are displayed in Figure 3.
Using the clinical discriminators “behavior
resting/approached/handled” and “circling or loss of balance
when blindfolded” 143 goats were correctly identified as brain-
negative (100% specificity), two were correctly identified as
brain-positive and six were falsely identified as brain-negative
(25% sensitivity).
A list of the clinical signs displayed by scrapie-positive and
negative goats is shown in Table 3.
A significantly higher proportion of lymphoid tissue only-
positive goats displayed tremor, and a significantly higher
proportion of brain-positive goats displayed abnormal behavior,
compared to the scrapie-negative group (two-tailed Fisher’s
exact test, P = 0.046 after applying Bonferroni’s correction for
multiple comparisons).
Table 4 lists the number and percentage of scrapie-
positive and negative goats with polymorphisms associated
with resistance to classical scrapie. A significantly higher
proportion of homozygous I142 goats compared to heterozygous
or homozygous M142 goats were affected by scrapie [two-tailed
Fisher’s exact test, P = 0.008 (II142 versus IM142) and 0.017 (II142
versus MM142) after applying Bonferroni’s correction for multiple
comparisons]. None of the goats carried an H154 allele.
When the OD value ratios were compared between four rapid
test-negative but confirmatory test positive and 39 rapid and
confirmatory test negative II142 goats, there was no significant
difference in the OD ratios: median 8.4% (range: 8.1–12.6%)
FIGURE 3 | Clinical discriminator for scrapie status based on classification
and regression tree analysis. The number in or above each bar is the number
of animals with a positive (red font and bar) and negative (black font and bar)
scrapie status based on examination of brain tissue by all confirmatory tests.
N is the number of animals remaining in each node (blue box = intermediary
node, yellow box = final node). The term “Negative” of “Positive” in each node
corresponds to the clinical scrapie status.
and median 9.4% (range: 3.0–18.7%), respectively; P = 0.95. The
single IM142 goat with a false negative ELISA result had a ratio
of 9.1%, which was close to the median of 64 goats with a
true negative result (median: 9.4%, range: 5.5–29.9%). All these
goats were RR211, QQ222 and PP240, SP240 or SS240.The median
age of the four II142 ELISA-false negative goats was 24 months
(range 24–72 months), which was not significantly different to
the 39 true negative goats (median 36, range: 24–72 months)
with the same genotype (P = 0.41). Similarly, the single ELISA-
false-negative IM142 goat was 24 months of age, which was close
to the median of the 64 true-negative IM142 goats (median 36,
range 24–72 months).
DISCUSSION
Continued monitoring by postmortem tests and whole herd
cull are currently the only options in case of a classical scrapie
outbreak in goats, although they are unlikely to succeed in the
eradication of classical scrapie in a country (EFSA, 2014). Both
options are costly (compensation for culled goats versus costs
for continuing monitoring for scrapie of fallen stock and healthy
slaughter goats over 18 months) and both have considerable
emotional impact on the farmer (herd cull versus continuous
restrictions and animal welfare implications due to scrapie).
In our case, whole herd cull was selected, which provided an
opportunity for more information about classical scrapie in
goats, complimentary to previous studies of a different goat
herd in Great Britain (González et al., 2009; Konold et al.,
2010), to compare the test sensitivity of clinical examinations
and screening TSE postmortem tests with confirmatory tests and
assess distribution of PrPSc in various tissues.
Based on the scrapie prevalence in this farm in the previous
4 years, which was below 4% and had declined over the previous
3 years, it was unexpected to find 5.3% of goats to be scrapie-
affected based on brain examination alone. The selection of
goats for transport was not completely random, and bias may
have occurred because clinical suspects were included. Thus,
the percentage of confirmed scrapie cases within the 151 goats
may not reflect the true prevalence in the whole herd. However,
this bias effect was likely to be small because of the high
proportion of clinical suspects previously in this herd that were
not confirmed pathologically.
Most striking was the finding that the ELISA, a postmortem
screening test approved for TSE testing by the European Union,
considerably underestimated the number of scrapie cases, with
only three cases (2%) being positive whereas a further five cases
were diagnosed by the confirmatory tests, IHC or WB, when
testing the same brain region (obex). The 2% detection rate is
in agreement with the estimated herd prevalence in previous
years, which was also based on the ELISA as an initial screening
test, but underestimates the real scrapie prevalence in this herd.
Previous studies have demonstrated that caprine scrapie cases
may be missed by reliance on the screening test alone (González
et al., 2009; Ortiz-Pelaez et al., 2015) but misdiagnosis of more
than 50% of cases in our study was unexpected, and it contradicts
results from another study where ELISA and IHC performed
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TABLE 3 | Individual signs in 151 goats assessed by the short protocol.
Scrapie-positive (brain)
N = 8
Scrapie-positive (LRS only)
N = 10
Scrapie-negative N = 133
Abnormal behavior 3 (37.5%) 2 (20.0%) 10 (7.5%)
Circling when blindfolded 2 (25.0%) 3 (30.0%) 3 (2.3%)
Menace response
Impaired 2 (25.0%) 0 26 (19.5%)
Exaggerated 1 (12.5%) 3 (30.0%) 16 (12.0%)
Tremor 1 (12.5%) 4 (40.0%) 14 (10.5%)
Abnormal mental status 1 (12.5%) 0 2 (1.5%)
Disequilibrium when blindfolded 1 (12.5%) 0 0
Ataxia or dysmetria 1 (12.5%) 1 (10.0%) 2 (1.5%)
Poor body condition (BCS ≤ 2) 0 3 (30.0%) 8 (6.0%)
Scratch test
Positive or inconsistent 0 0 8 (6.0%)
Inconclusive 0 0 1 (0.8%)
Hair loss
Poll 4 (50.0%) 5 (50.0%) 68 (51.1%)
Nose 1 (12.5%) 0 10 (7.5%)
Neck 0 1 (10.0%) 2 (1.5%)
Side abdomen/chest 0 1 (10.0%) 1 (0.8%)
Rump 0 1 (10.0%) 1 (0.8%)
Tail base 0 1 (10.0%) 0
Eyelid 0 0 7 (5.3%)
Shoulder 0 0 2 (1.5%)
Back 0 0 1 (0.8%)
Hair short
Shoulder 1 (12.5%) 0 4 (3.0%)
Neck 0 2 (20.0%) 11 (8.3%)
Rump 0 1 (10.0%) 9 (6.8%)
Poll 0 1 (10.0%) 5 (3.8%)
Side abdomen/chest 0 1 (10.0%) 1 (0.8%)
Tail base 0 0 16 (12.0%)
Eyelid 0 0 1 (0.8%)
Back 0 0 1 (0.8%)
similarly in the detection of scrapie in French goats (Corbière
et al., 2013a). A recent study in goats demonstrated that rapid
TABLE 4 | Number and frequency of goats with selected allele variants.
Number of goats with allele variants (proportion)
Polymorphism at codon Scrapie-positive (18) Scrapie-negative (133)
II142 14 (78%) 44 (33%)
IM142 4 (22%) 67 (50%)
MM142 0 22 (17%)
IM142 PP240 2 (4%) 53 (96%)
IM142 SP240 1 (6%) 15 (94%)
NN146 18 (100%) 131 (98%)
NS146 0 2 (2%)
RR211 18 (100%) 128 (96%)
RQ211 0 5 (4%)
QQ222 18 (100%) 130 (98%)
QK222 0 3 (2%)
screening tests performed well in clinically affected animals
but were less sensitive in the pre-clinical phase, which was
dependent on PRNP polymorphisms. In particular, the presence
of the M142 allele appeared to compromise to some extent the
sensitivity of the Bio-Rad screening tests (Simmons et al., 2020).
In the present study, however, four were II142 and only one was
M142 heterozygous. There was no evidence that the ELISA-false
negative cases had a higher OD value than the true negative cases,
and it also did not seem to be influenced by breed and age. It
confirmed disease in clinical suspects when PrPSc accumulation
in the brain appears to be moderate to high as judged by IHC
(Konold et al., 2010; Niedermeyer et al., 2016) but its reliability
appears to be poor in asymptomatic cases, even goats that do not
carry an M142 allele. Asymptomatic animals are likely to represent
the majority of goats targeted by this screening test as part of the
active scrapie surveillance. Of the two confirmatory tests used,
WB and IHC, both performed equally well, with only one sample
each classified as positive by one but not the other test. The WB-
negative but IHC-positive sample was caudal medulla because
obex was not available for WB testing in this animal, and testing
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of tissue caudal to the target area may explain a negative test result
in the Western blot.
A further 10 goats presented with PrPSc in lymphoid tissue
only, indicating infection with the scrapie agent and suggestive
of an earlier stage of disease. This was expected from previous
studies in goats where lymphoid tissue in addition to brain
was tested (González et al., 2009; Corbière et al., 2013b; Ortiz-
Pelaez et al., 2015; Niedermeyer et al., 2016; Georgiadou et al.,
2017). Also in agreement with previous studies where at least
five different lymphoid tissues were tested (González et al., 2009;
Niedermeyer et al., 2016), the medial retropharyngeal LN was
the tissue that most consistently presented with PrPSc by IHC,
followed by palatine tonsil but there was no consistent hierarchy
at an individual animal level. RAMALT was positive in 50% of
the cases, which is similar to the 42% reported in an earlier
study (González et al., 2009), but considerably lower compared
to sheep with more than 85% (González et al., 2006), and, if used
as ante mortem test, sensitivity may even be lower because of
the considerably smaller amount of tissue that can be collected
in a live animal.
One animal (2169) had detectable PrPSc only in the
pre-scapular (superficial cervical) LN, which has previously
been reported for a different scrapie-affected farm in the
United Kingdom (González et al., 2010). As observed in
this previous study for cases with limited lymphoid tissue
involvement, immunolabeling was restricted to tingible body
macrophages in this LN. It may indicate an earlier stage of
infection as demonstrated for sheep with classical scrapie (van
Keulen et al., 2002). Why only this LN was affected is not
known; the same phenomenon was not observed in two other
scrapie-affected goats with the same PRNP genotype. This
may represent a different pathogenesis, for example, iatrogenic
infection by subcutaneous injection with a contaminated needle
in the neck region, of which afferent lymph vessels drain in
this LN (Tanudimadja, 1973). It may also be caused by a
different scrapie strain or some genetic or animal factors that
led to limited PrPSc accumulation in peripheral LNs. This LN
is generally not tested in scrapie studies so it is not known
how often it occurs in scrapie outbreaks. Additional, deeper
section examined from this LN by IHC were negative, which
suggested that PrPSc accumulation was limited, possibly because
of a very early stage of infection, and could easily be missed.
Surprisingly, this goat was a clinical scrapie suspect displaying
tremor, hair loss, mild ataxia, poor body condition, and clockwise
circling when blindfolded. Histologically, there was diffuse mild
vacuolation of the white matter tracts in thalamus, cerebrum, and
cerebellum, occasionally accompanied by astrocytes with mild
swollen vesicular astrocytes, which was interpreted as artifactual
change although could have also been the result of a toxic or
metabolic insult to the brain, but neither liver not kidney was
available for further investigation.
None of the goats in the affected herd presented with PrPSc in
brain only, without detectable PrPSc in lymphoid tissue, whereas
in a previously reported outbreak of scrapie in British goats this
was the case in four of 72 scrapie cases (6%), of which all were
homo- or heterozygous M142 (González et al., 2009). This may
be explained by the lower number of scrapie cases having these
PRNP polymorphisms in the present study (three versus 32 in the
other outbreak) or the scrapie strains were different.
A significantly greater proportion of goats with scrapie was
homozygous for I142. There is some evidence that the scrapie
risk is reduced in goats homozygous for M142 but also in goats
heterozygous for M142 and homozygous for P240 (Barillet et al.,
2009; Corbière et al., 2013b). However, in the current study,
there were actually two goats with the IM142 PP240 combination
that had scrapie compared to one goat with the IM142 SP142
combination. Indeed, a review of the literature concluded that
the M142 allele is only associated with incomplete resistance to
classical scrapie [EFSA BIOHAZ Panel (EFSA Panel on Biological
Hazards (BIOHAZ) et al., 2017)]. None of the goats that carried
a single allele associated with increased resistance (Q211, K222,
S146) were scrapie-positive, which was expected from previous
studies [EFSA Panel on Biological Hazards (BIOHAZ) et al.,
2017] but the number of goats with these polymorphisms in the
selected herd subpopulation was unexpected. The billies used
on this farm did not carry a K222 allele, and to our knowledge
artificial insemination was not used, which suggests that this
allele must have been present in the female population and would
have only been detected by genotyping more goats if a scrapie
eradication program by genotype selection was considered. Given
that the most recent national survey in the United Kingdom
detected a QK222 genotype frequency of only 0.6% in Saanen,
Toggenburg, and their crossbreds (Goldmann et al., 2016), which
were the breeds present on the farm, finding 2% out of 151
goats with this polymorphism was unexpected. Similarly, the
frequency of the NS146 genotype was mostly limited to Boer goats
and in dairy goats was estimated to be 0.2% or less (Goldmann
et al., 2011, 2016), whereas 2% (two Toggenburg goats) had this
polymorphism in the study reported here.
Sensitivity of the clinical examination was expectedly poor
although better than in a previous study where sensitivity
was 3.9% (only clinical suspects considered scrapie-affected)
and 11.7% (including clinically inconclusive goats) using brain
examination as gold standard (Konold et al., 2010). This
may be due to the inclusion of blindfolding in the short
examination protocol, which as the classification tree suggested,
was an important clinical discriminator. However, by including
response to blindfolding, specificity, which was 99.6% (clinical
suspects only) and 88.5% (with clinically inconclusive included)
in the previous study, decreased slightly. Classification tree
analysis indicated that only two clinical signs, abnormal
behavior (nervousness or dullness) and abnormal responses to
blindfolding (loss of balance or circling), were important for
a suspect clinical diagnosis of scrapie with similar sensitivity
although more examinations of goats with and without scrapie
are necessary to confirm this. In general, circling is a sign more
often observed in sheep with atypical scrapie (Onnasch et al.,
2004; Konold et al., 2006; Simmons et al., 2010) than sheep or
goats with classical scrapie (Laven, 1990; Ulvund, 2006; Konold
et al., 2010) but blindfolding, which may elicit circling, is rarely
used as part of the examination protocol.
None of the goats that tested positive for scrapie on brain
showed signs of pruritus. Hair loss suggestive of pruritus was
found in scrapie-positive and negative goats and the scratch
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test was only positive in scrapie-negative goats, which implied
that scrapie goats displayed the non-pruritic form of the disease
(Konold et al., 2010). It is possible that some of the scrapie-
negative goats suffered from other conditions leading to hair loss
and pruritus, such as mite or lice infestation (Jackson, 1986),
which we did not investigate. Hair loss may also have non-
infectious causes, such as friction due to poorly designed feeding
stations. Indeed, a study in the United Kingdom has identified
skin lesions, including hair loss, and pruritus as one of the
major welfare issues in commercial dairy goat farms (Anzuino
et al., 2010). It was surprising that neurological signs such as
ataxia, tremor, and loss of balance or circling were not observed
significantly more frequently in goats with PrPSc in brain. This
may be due to other conditions that may have been present in the
brain-negative population. For example, tremor in large animals
as single sign may have no obvious cause and can even be a sign in
frightened animals (Mayhew, 2009). It is also possible that some
scrapie-affected goats were in an earlier stage of clinical disease
when clear neurological signs may be more subtle, or absent, as
demonstrated in a study where scrapie goats were monitored over
time (Konold et al., 2010).
Listeriosis was diagnosed in two goats. In one goat
neurological signs developed after the clinical examination and
the clinical findings of nystagmus and head tilt were consistent
with a vestibular system dysfunction as seen in listeriosis
(Braun et al., 2002), which is unlike scrapie. Ideally, all clinical
examinations should have been carried out within a few days
prior to cull as clinical signs may develop after the clinical
examination. This was not always possible for logistical reasons,
but 87% of examinations were carried out within 14 days prior
to cull. The other goat with listeriosis was clinically inconclusive
because of the display of a head tremor and inconsistent circling
when blindfolded. It implied that a neurological disease was
present and a more thorough neurological examination might
have detected other abnormalities associated with listeriosis, such
as facial asymmetry and reduced sensory perception (Braun
et al., 2002), or more signs developed over the 5 days between
examination and cull.
CONCLUSION
The results of this study continue to highlight the limitations
of the Bio-Rad ELISA as brain screening test to diagnose
classical scrapie in goats, and other or additional tests should
be considered. It is recommended to include testing of the
medial retropharyngeal LN or palatine tonsil, which are also
located at the head that is generally submitted for testing and are
less prone to rapid autolysis, to increase the sensitivity of goat
scrapie surveillance.
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